171 related articles for article (PubMed ID: 31728288)
21. Smart Superstructures with Ultrahigh pH-Sensitivity for Targeting Acidic Tumor Microenvironment: Instantaneous Size Switching and Improved Tumor Penetration.
Li HJ; Du JZ; Liu J; Du XJ; Shen S; Zhu YH; Wang X; Ye X; Nie S; Wang J
ACS Nano; 2016 Jul; 10(7):6753-61. PubMed ID: 27244096
[TBL] [Abstract][Full Text] [Related]
22. Biological Effects of Nanoparticles on Macrophage Polarization in the Tumor Microenvironment.
Reichel D; Tripathi M; Perez JM
Nanotheranostics; 2019; 3(1):66-88. PubMed ID: 30662824
[TBL] [Abstract][Full Text] [Related]
23. Combination antitumor immunotherapy with VEGF and PIGF siRNA via systemic delivery of multi-functionalized nanoparticles to tumor-associated macrophages and breast cancer cells.
Song Y; Tang C; Yin C
Biomaterials; 2018 Dec; 185():117-132. PubMed ID: 30241030
[TBL] [Abstract][Full Text] [Related]
24. Zoledronic acid prevents the tumor-promoting effects of mesenchymal stem cells via MCP-1 dependent recruitment of macrophages.
Jia XH; Du Y; Mao D; Wang ZL; He ZQ; Qiu JD; Ma XB; Shang WT; Ding D; Tian J
Oncotarget; 2015 Sep; 6(28):26018-28. PubMed ID: 26305552
[TBL] [Abstract][Full Text] [Related]
25. Hybrid polymeric nanoparticles with high zoledronic acid payload and proton sponge-triggered rapid drug release for anticancer applications.
Xiao MC; Chou YH; Hung YN; Hu SH; Chiang WH
Mater Sci Eng C Mater Biol Appl; 2020 Nov; 116():111277. PubMed ID: 32806243
[TBL] [Abstract][Full Text] [Related]
26. Multifunctional ROS-Responsive and TME-Modulated Lipid-Polymer Hybrid Nanoparticles for Enhanced Tumor Penetration.
Ni R; Huang L; Li Z; Zhang W; Wang Y; Shen Y; Wang J; Lu W
Int J Nanomedicine; 2022; 17():5883-5897. PubMed ID: 36478745
[TBL] [Abstract][Full Text] [Related]
27. Dual-Stage Irradiation of Size-Switchable Albumin Nanocluster for Cascaded Tumor Enhanced Penetration and Photothermal Therapy.
He P; Lei Q; Yang B; Shang T; Shi J; Ouyang Q; Wang W; Xue L; Kong F; Li Z; Huang J; Liu L; Guo J; Brinker CJ; Liu K; Zhu W
ACS Nano; 2022 Sep; 16(9):13919-13932. PubMed ID: 36082976
[TBL] [Abstract][Full Text] [Related]
28. Tumor microenvironment targeting with dual stimuli-responsive nanoparticles based on small heat shock proteins for antitumor drug delivery.
Shi K; Wang Y; Zhou X; Gui H; Xu N; Wu S; He C; Zhao Z
Acta Biomater; 2020 Sep; 114():369-383. PubMed ID: 32688090
[TBL] [Abstract][Full Text] [Related]
29. Repolarization of macrophages to improve sorafenib sensitivity for combination cancer therapy.
Huang L; Xu R; Li W; Lv L; Lin C; Yang X; Yao Y; Saw PE; Xu X
Acta Biomater; 2023 May; 162():98-109. PubMed ID: 36931417
[TBL] [Abstract][Full Text] [Related]
30. The application of nanoparticles in cancer immunotherapy: Targeting tumor microenvironment.
Yang M; Li J; Gu P; Fan X
Bioact Mater; 2021 Jul; 6(7):1973-1987. PubMed ID: 33426371
[TBL] [Abstract][Full Text] [Related]
31. Synergistic targeting tenascin C and neuropilin-1 for specific penetration of nanoparticles for anti-glioblastoma treatment.
Kang T; Zhu Q; Jiang D; Feng X; Feng J; Jiang T; Yao J; Jing Y; Song Q; Jiang X; Gao X; Chen J
Biomaterials; 2016 Sep; 101():60-75. PubMed ID: 27267628
[TBL] [Abstract][Full Text] [Related]
32. Tumor Microenvironment-Responsive Shell/Core Composite Nanoparticles for Enhanced Stability and Antitumor Efficiency Based on a pH-Triggered Charge-Reversal Mechanism.
Luo Q; Shi W; Wang P; Zhang Y; Meng J; Zhang L
Pharmaceutics; 2021 Jun; 13(6):. PubMed ID: 34208641
[TBL] [Abstract][Full Text] [Related]
33. Autophagy responsive intra-intercellular delivery nanoparticles for effective deep solid tumor penetration.
Wang F; Xie D; Lai W; Zhou M; Wang J; Xu R; Huang J; Zhang R; Li G
J Nanobiotechnology; 2022 Jun; 20(1):300. PubMed ID: 35752856
[TBL] [Abstract][Full Text] [Related]
34. Integrin-mediated active tumor targeting and tumor microenvironment response dendrimer-gelatin nanoparticles for drug delivery and tumor treatment.
Hu G; Zhang H; Zhang L; Ruan S; He Q; Gao H
Int J Pharm; 2015 Dec; 496(2):1057-68. PubMed ID: 26598487
[TBL] [Abstract][Full Text] [Related]
35. Enhanced Cellular Internalization and On-Demand Intracellular Release of Doxorubicin by Stepwise pH-/Reduction-Responsive Nanoparticles.
Li F; Chen WL; You BG; Liu Y; Yang SD; Yuan ZQ; Zhu WJ; Li JZ; Qu CX; Zhou YJ; Zhou XF; Liu C; Zhang XN
ACS Appl Mater Interfaces; 2016 Nov; 8(47):32146-32158. PubMed ID: 27933846
[TBL] [Abstract][Full Text] [Related]
36. cRGDyK modified pH responsive nanoparticles for specific intracellular delivery of doxorubicin.
Qiu L; Hu Q; Cheng L; Li L; Tian C; Chen W; Chen Q; Hu W; Xu L; Yang J; Cheng L; Chen D
Acta Biomater; 2016 Jan; 30():285-298. PubMed ID: 26602824
[TBL] [Abstract][Full Text] [Related]
37. A hybrid bacterium with tumor-associated macrophage polarization for enhanced photothermal-immunotherapy.
Zhao J; Huang H; Zhao J; Xiong X; Zheng S; Wei X; Zhou S
Acta Pharm Sin B; 2022 Jun; 12(6):2683-2694. PubMed ID: 35755281
[TBL] [Abstract][Full Text] [Related]
38. Targeted treatment of triple-negative-breast cancer through pH-triggered tumour associated macrophages using smart theranostic nanoformulations.
Scialla S; Hanafy MS; Wang JL; Genicio N; Costa Da Silva M; Costa M; Oliveira-Pinto S; Baltazar F; Gallo J; Cui Z; Bañobre-López M
Int J Pharm; 2023 Feb; 632():122575. PubMed ID: 36603672
[TBL] [Abstract][Full Text] [Related]
39. Synthesis of micellar-like terpolymer nanoparticles with reductively-cleavable cross-links and evaluation of efficacy in 2D and 3D models of triple negative breast cancer.
Monteiro PF; Gulfam M; Monteiro CJ; Travanut A; Abelha TF; Pearce AK; Jerôme C; Grabowska AM; Clarke PA; Collins HM; Heery DM; Gershkovich P; Alexander C
J Control Release; 2020 Jul; 323():549-564. PubMed ID: 32371266
[TBL] [Abstract][Full Text] [Related]
40. Tumor microcalcification-mediated relay drug delivery for photodynamic immunotherapy of breast cancer.
Jian H; Wang X; Song P; Wu X; Zheng R; Wang Y; Zhang H
Acta Biomater; 2022 Mar; 140():518-529. PubMed ID: 34923096
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
